4483N Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
High Profitability / MarginsSustained high gross and operating margins reflect strong product economics from curated healthcare data and analytics. Durable margins create internal funding for R&D and platform improvements, supporting long-term earnings resilience even if revenue growth moderates.
Data-driven Recurring Revenue ModelCore business sells recurring access to curated medical datasets and analytics to insurers, pharma and others. Sticky contracts and high switching costs in healthcare analytics support predictable revenue, enabling steady customer lifetime value and upsell opportunities over years.
Positive Free Cash Flow And ScaleTTM free cash flow near ¥8.0B and steady asset/equity growth show the business can convert earnings into cash to fund operations and reinvestment. That cash generation, while variable, underpins strategic investments and long-term platform scaling.
Bears Say
Decelerating Revenue GrowthTop-line growth slowing to ~6% TTM reduces the runway for operating leverage and margin expansion. For a data analytics provider, weaker revenue momentum can signal market saturation, tougher competition for enterprise contracts, or slower adoption of higher-margin services.
Rising LeverageIncreasing debt-to-equity to roughly 0.64 indicates greater reliance on borrowed funds to finance growth. Higher leverage reduces financial flexibility, raises interest exposure, and can constrain strategic choices during downturns or when pursuing acquisitions.
Volatile Cash Flow ConversionOperating and free cash flow have swung materially (negative in 2024, rebound in 2025, then decline TTM). This inconsistency weakens confidence in reliable cash conversion, complicating capital allocation for sustained product development or shareholder returns.
4483N FAQ
What was JMDC Inc.’s price range in the past 12 months?
Currently, no data Available
What is JMDC Inc.’s market cap?
JMDC Inc.’s market cap is $23.06B.
When is JMDC Inc.’s upcoming earnings report date?
JMDC Inc.’s upcoming earnings report date is Aug 05, 2026 which is in 5 days.
How were JMDC Inc.’s earnings last quarter?
JMDC Inc. released its earnings results on May 08, 2026. The company reported $3.228 earnings per share for the quarter, missing the consensus estimate of $3.881 by -$0.654.
Is JMDC Inc. overvalued?
According to Wall Street analysts JMDC Inc.’s price is currently Undervalued.
Does JMDC Inc. pay dividends?
JMDC Inc. does not currently pay dividends.
What is JMDC Inc.’s EPS estimate?
JMDC Inc.’s EPS estimate is 0.98.
How many shares outstanding does JMDC Inc. have?
JMDC Inc. has 65,446,205 shares outstanding.
What happened to JMDC Inc.’s price movement after its last earnings report?
JMDC Inc. reported an EPS of $3.228 in its last earnings report, missing expectations of $3.881. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of JMDC Inc.?
Currently, no hedge funds are holding shares in MX:4483N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JMDC Inc.
JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.
4483N Stock 12 Month Forecast
Average Price Target
$458.16